
Rodney P. Swartz
Examiner (ID: 3558, Phone: (571)272-0865 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1802, 1641 |
| Total Applications | 1651 |
| Issued Applications | 1191 |
| Pending Applications | 107 |
| Abandoned Applications | 361 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13077093
[patent_doc_number] => 10058601
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-28
[patent_title] => Attenuated
[patent_app_type] => utility
[patent_app_number] => 15/594451
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 10257
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15594451
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/594451 | Attenuated | May 11, 2017 | Issued |
Array
(
[id] => 12029578
[patent_doc_number] => 20170319677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'TEMPERATURE SENSITIVE MULTIVALENT BORDETELLA AVIUM VACCINES'
[patent_app_type] => utility
[patent_app_number] => 15/586110
[patent_app_country] => US
[patent_app_date] => 2017-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4989
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15586110
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/586110 | Temperature sensitive multivalent | May 2, 2017 | Issued |
Array
(
[id] => 13714403
[patent_doc_number] => 20170368156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => ATTENUATED SALMONELLA BACTERIA AND METHODS OF USING
[patent_app_type] => utility
[patent_app_number] => 15/583776
[patent_app_country] => US
[patent_app_date] => 2017-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15583776
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/583776 | Attenuated | Apr 30, 2017 | Issued |
Array
(
[id] => 16518701
[patent_doc_number] => 10869903
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-22
[patent_title] => Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease
[patent_app_type] => utility
[patent_app_number] => 15/495522
[patent_app_country] => US
[patent_app_date] => 2017-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 99
[patent_figures_cnt] => 190
[patent_no_of_words] => 139698
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15495522
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/495522 | Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease | Apr 23, 2017 | Issued |
Array
(
[id] => 11851732
[patent_doc_number] => 20170226224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'PROTEIN PURIFICATION'
[patent_app_type] => utility
[patent_app_number] => 15/494362
[patent_app_country] => US
[patent_app_date] => 2017-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13267
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15494362
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/494362 | PROTEIN PURIFICATION | Apr 20, 2017 | Abandoned |
Array
(
[id] => 11836724
[patent_doc_number] => 20170218443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'MSP NANOPORES AND RELATED METHODS'
[patent_app_type] => utility
[patent_app_number] => 15/488311
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 31148
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15488311
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/488311 | MSP nanopores and related methods | Apr 13, 2017 | Issued |
Array
(
[id] => 16475068
[patent_doc_number] => 10849988
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-01
[patent_title] => Hydrogel for engineered immune response to D-chirality peptides
[patent_app_type] => utility
[patent_app_number] => 16/092202
[patent_app_country] => US
[patent_app_date] => 2017-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 12705
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16092202
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/092202 | Hydrogel for engineered immune response to D-chirality peptides | Apr 9, 2017 | Issued |
Array
(
[id] => 11823178
[patent_doc_number] => 20170212115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'ELISPOT METHOD HAVING TWO FILTER SYSTEMS'
[patent_app_type] => utility
[patent_app_number] => 15/480588
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5804
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480588
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/480588 | ELISPOT method having two filter systems | Apr 5, 2017 | Issued |
Array
(
[id] => 11986740
[patent_doc_number] => 20170290895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-12
[patent_title] => 'HEARTWORM VACCINE, METHODS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/480345
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8378
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480345
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/480345 | Heartworm vaccine, methods and uses thereof | Apr 4, 2017 | Issued |
Array
(
[id] => 11964925
[patent_doc_number] => 20170269079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'Mycobacterium Antigens'
[patent_app_type] => utility
[patent_app_number] => 15/475472
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9618
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15475472
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/475472 | Mycobacterium Antigens | Mar 30, 2017 | Abandoned |
Array
(
[id] => 11756093
[patent_doc_number] => 20170202959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'ADJUVANT COMPOSITIONS AND RELATED METHODS'
[patent_app_type] => utility
[patent_app_number] => 15/467585
[patent_app_country] => US
[patent_app_date] => 2017-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 26955
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15467585
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/467585 | Adjuvant compositions and related methods | Mar 22, 2017 | Issued |
Array
(
[id] => 13035403
[patent_doc_number] => 10039814
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-07
[patent_title] => Glycoconjugate vaccines
[patent_app_type] => utility
[patent_app_number] => 15/465312
[patent_app_country] => US
[patent_app_date] => 2017-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 28
[patent_no_of_words] => 9079
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 230
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15465312
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/465312 | Glycoconjugate vaccines | Mar 20, 2017 | Issued |
Array
(
[id] => 13179885
[patent_doc_number] => 10105430
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-23
[patent_title] => Method for preventing or treating
[patent_app_type] => utility
[patent_app_number] => 15/463557
[patent_app_country] => US
[patent_app_date] => 2017-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 31
[patent_no_of_words] => 27690
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15463557
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/463557 | Method for preventing or treating | Mar 19, 2017 | Issued |
Array
(
[id] => 14099285
[patent_doc_number] => 20190091318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => ADHESIN TIP MULTIEPITOPE FUSION ANTIGEN PLATFORM AND VACCINES AND THEIR USE IN THE TREATMENT OF ENTEROTOXIGENIC DIARRHEA
[patent_app_type] => utility
[patent_app_number] => 16/085884
[patent_app_country] => US
[patent_app_date] => 2017-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12387
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085884
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085884 | Adhesin tip multiepitope fusion antigen platform and vaccines and their use in the treatment of enterotoxigenic diarrhea | Mar 19, 2017 | Issued |
Array
(
[id] => 17220710
[patent_doc_number] => 11173193
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-16
[patent_title] => Immunobiological products
[patent_app_type] => utility
[patent_app_number] => 16/085033
[patent_app_country] => US
[patent_app_date] => 2017-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 42277
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085033
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085033 | Immunobiological products | Mar 14, 2017 | Issued |
Array
(
[id] => 16030773
[patent_doc_number] => 10677797
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-09
[patent_title] => Assays and methods for detecting mycobacterial infections
[patent_app_type] => utility
[patent_app_number] => 16/083807
[patent_app_country] => US
[patent_app_date] => 2017-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 18
[patent_no_of_words] => 19186
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16083807
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/083807 | Assays and methods for detecting mycobacterial infections | Mar 9, 2017 | Issued |
Array
(
[id] => 14040811
[patent_doc_number] => 20190076512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => METHODS AND KITS FOR USE IN PREVENTING AND TREATING VULVOVAGINAL CANDIDIASIS
[patent_app_type] => utility
[patent_app_number] => 16/081062
[patent_app_country] => US
[patent_app_date] => 2017-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16417
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16081062
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/081062 | Methods and kits for use in preventing and treating vulvovaginal candidiasis | Mar 6, 2017 | Issued |
Array
(
[id] => 14098933
[patent_doc_number] => 20190091142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => METHOD OF TREATING AN EYE DISORDER BY INHIBITING OR DISRUPTING BACTERIAL BIOFILM FORMATION
[patent_app_type] => utility
[patent_app_number] => 16/082151
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5305
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16082151
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/082151 | Method of treating an eye disorder by inhibiting or disrupting bacterial biofilm formation | Mar 2, 2017 | Issued |
Array
(
[id] => 16933768
[patent_doc_number] => 20210199657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => IMMUNOGENIC PEPTIDES AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/079629
[patent_app_country] => US
[patent_app_date] => 2017-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079629
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/079629 | IMMUNOGENIC PEPTIDES AND USE THEREOF | Feb 23, 2017 | Abandoned |
Array
(
[id] => 13926231
[patent_doc_number] => 20190046631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus
[patent_app_type] => utility
[patent_app_number] => 16/078963
[patent_app_country] => US
[patent_app_date] => 2017-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37363
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16078963
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/078963 | Proteins and nucleic acids useful in vaccines targeting | Feb 21, 2017 | Issued |